CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- 4/A Derivatives Options or other derivatives
- 4/A Open-market sale General Counsel sold 4,993 shares at $15.78 ($78,790)
- 4/A Open-market sale Chief Medical Officer sold 3,789 shares at $15.78 ($59,790)
- 4 Open-market sale General Counsel sold 4,993 shares at $15.74 ($78,590)
- 4 Open-market sale Chief Medical Officer sold 3,789 shares at $15.74 ($59,639)
- 4 Exercise or conversion Chief Financial Officer acquired 3,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 3,800 shares at $18.01 ($68,438)
- 4 Grant or award Director acquired 69,339 shares (grant or award)
- 4/A Derivatives Options or other derivatives
Page 4 of 12 · 233 filings